Stinging Nettle Root — Research Profile

In vitro studies demonstrate that nettle root lignans bind SHBG and can displace testosterone from SHBG binding sites, which would theoretically increase free (bioavailable) testosterone. However, clinical studies measuring actual free testosterone changes from nettle root supplementation alone are limited. The SHBG-binding effect is well-documented in laboratory settings but clinical quantification in humans needs more research. Most clinical trials have focused on prostate symptom outcomes rather than hormone levels.

No, they are different parts of the same plant with different uses. Nettle root (Urtica dioica radix) is used for prostate health, SHBG binding, and BPH symptoms. Nettle leaf (Urtica dioica folium) is used for allergies, inflammation, and joint pain, and contains different active compounds (including histamine and vitamin K). When shopping for men's health benefits, specifically look for "nettle root" extract, not "nettle leaf" or "stinging nettle" (which usually refers to the leaf).

Yes, this is one of the best-studied herbal combinations for prostate health. The PRO 160/120 formulation (saw palmetto 160mg + nettle root 120mg) has been studied in multiple RCTs and was found comparable to finasteride for BPH symptom relief with fewer side effects. Many European urologists recommend this combination as a first-line phytotherapy before considering pharmaceutical options.

Human trials used oral dried nettle root extract in capsules, either alone at 1,200 mg/day or as the 120 mg twice-daily root fraction of the WS 1541 saw palmetto combination. The combination extract has the most supportive trial data for urinary symptoms, while standalone root extract also produced significant symptom improvement. No study has directly compared teas, tinctures, or whole-root powder against these standardized extracts, so the encapsulated root extract is the evidence-backed form.

The primary human benefit is relief of lower urinary tract symptoms from benign prostatic hyperplasia: a 6-month randomized trial cut the International Prostate Symptom Score from 19.8 to 11.8, raised peak urinary flow by 8.2 mL/s versus 3.4 with placebo, and modestly reduced prostate volume (40.1 to 36.3 cc). NCCIH characterizes this as limited but real evidence that nettle root may improve some BPH symptoms. A proposed mechanism is that nettle root lignans bind sex hormone-binding globulin, though that binding was shown only in vitro and does not by itself prove clinical benefit.

In the standalone BPH trial, men took 300 mg capsules twice daily, twice a day, totaling 1,200 mg/day of nettle root extract for 8 weeks. In the saw palmetto combination (WS 1541), the nettle component was 120 mg of root extract twice daily. There is no official recommended daily allowance for an herb; these trial doses are the practical reference range, and products vary in extract concentration so the labeled root-extract amount matters more than capsule count.

Trials dosed nettle root twice daily but did not compare morning versus evening timing, so no optimal time of day has been demonstrated. Because MSKCC notes nettle has diuretic activity, some men prefer to avoid a dose close to bedtime to limit overnight urination, which is often already a BPH complaint. Splitting the daily amount into two doses, as the studies did, is the only timing detail actually supported by the trial protocols.

Controlled BPH trials reported no side effects at all, and NCCIH notes that when adverse effects occur they are usually mild and gastrointestinal. MSKCC documents rarer case reports, including hypoglycemia in a 78-year-old man taking nettle for BPH, so men on blood-sugar-lowering treatment should be alert to that possibility. Serious reactions are uncommon with the root, but any allergic response (rash, itching, swelling) warrants stopping the supplement.

MSKCC lists mostly theoretical interactions: nettle may add to the effect of diuretics and may enhance blood-pressure-lowering (antihypertensive) drugs, and animal data suggest it can inhibit CYP450 enzymes that metabolize many medications, though the clinical relevance in humans is not established. A case report of hypoglycemia in a man taking nettle for BPH raises a caution alongside diabetes medications. Separately, NCCIH notes the tannins in nettle can reduce absorption of iron supplements, so those should be taken several hours apart.

Nettle root is most relevant for men with mild-to-moderate benign prostatic hyperplasia who want to ease urinary symptoms such as weak stream, urgency, or incomplete emptying, since that is the population studied. It is not the right product for allergy or joint complaints, which are associated with nettle leaf rather than root. Men on diuretics, blood-pressure or diabetes medication, and anyone with significant prostate symptoms, should confirm suitability with a clinician before relying on it, and BPH should be medically evaluated rather than self-treated.

In a randomized double-blind trial of 100 men with benign prostatic hyperplasia (BPH), 1,200 mg/day of nettle root extract produced a statistically significant drop in urinary symptom (AUA) scores over an 8-week treatment period. A larger 6-month trial similarly lowered the International Prostate Symptom Score from 19.8 to 11.8. These studies report change at fixed endpoints rather than week-by-week, so allow at least several weeks of consistent use before judging any effect on urinary symptoms.

Nettle root has been used safely for months in controlled BPH trials: a 6-month randomized study reported no side effects in either arm, and a combination of nettle root and saw palmetto (WS 1541) was taken for 24 weeks with an additional 24-week open extension and excellent tolerability. NCCIH describes Urtica dioica as generally well-tolerated with at most mild gastrointestinal effects. Safety beyond roughly one year has not been formally established, so extended daily use is best kept under periodic medical review, especially in men managing prostate symptoms.

No toxic threshold or upper limit for nettle root has been established in humans. Clinical trials used doses up to 1,200 mg/day of root extract with no reported side effects, and NCCIH notes that adverse effects, when they occur, are typically mild and gastrointestinal. There is no evidence that taking substantially more improves prostate outcomes, so exceeding studied doses adds risk without demonstrated benefit.

The best-studied pairing is nettle root with saw palmetto (Sabal serrulata): the fixed combination WS 1541, delivering 120 mg of nettle root extract twice daily, improved lower urinary tract symptoms in a 257-man trial with tolerability comparable to placebo. One caution is that nettle contains tannins that can bind dietary iron, so NCCIH advises separating it from iron supplements. There is no direct trial evidence for stacking nettle root with unrelated supplements.

Confirm the product is nettle ROOT (Urtica dioica radix) rather than nettle leaf or aerial parts, because the root is what BPH trials studied while the leaf is used for different purposes such as allergy and joint symptoms. Clinical evidence rests on defined root extracts such as WS 1031 (used in the WS 1541 combination) and dried root extract standardized to the studied daily amounts; no single universal marker compound defines potency. Products that specify the plant part, the extract, and a per-capsule root-extract dose in the studied range are the most defensible choice.